Jove
Visualize
Contact Us

Related Experiment Videos

Malignant hyperthermia, a surgeon's nightmare.

M K Lowe

    The Journal of Foot Surgery
    |March 1, 1985
    PubMed
    Summary

    Malignant hyperthermia is a dangerous anesthesia emergency triggered by volatile agents, causing rapid temperature spikes. Immediate treatment involves stopping anesthesia, cooling the patient, and administering dantrolene.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.

    European journal of clinical nutrition·1994
    Same author

    USE OF HEMOLYZED SPECIMENS IN THE KAHN TEST.

    American journal of public health (New York, N.Y. : 1912)·1925
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Malignant hyperthermia (MH) is a rare but life-threatening pharmacogenetic disorder.
    • It is primarily triggered by volatile anesthetic agents and succinylcholine during surgical procedures.

    Observation:

    • Anesthesia administration can precipitate a hypermetabolic crisis in susceptible individuals.
    • Patients experience a rapid and severe increase in body temperature, potentially reaching 109°F.
    • This hypermetabolic state involves muscle rigidity, tachycardia, and acidosis.

    Findings:

    • Immediate cessation of the triggering anesthetic agent is the first critical step in management.
    • External and internal cooling measures, including ice baths and cooled IV fluids, are essential.
    • Dantrolene sodium is the pharmacologic treatment of choice for reversing MH crisis.

    Implications:

    • Prompt recognition and intervention are crucial to prevent mortality and long-term sequelae.
    • Understanding MH triggers and management protocols is vital for all healthcare professionals involved in anesthesia.
    • Further research into genetic predispositions and novel therapeutic strategies for MH is warranted.

    Related Experiment Videos